14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today EGRX ranks #12452 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$46.67 (-1.99%)

Volume: 93k

Closed: Dec 08, 2021

Hollow Logo Score: -3.121

Eagle Pharmaceuticals Stock Forecast

$46.67 (-1.99%)

Volume: 93k

Closed: Dec 08, 2021

Score Hollow Logo -3.121
Which way will EGRX go? Request
Key Stats
Beta 0.63
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 29 and the stock is currently not being overbought or oversold

Eagle Pharmaceuticals stock price ended on $46.67 on Wednesday after losing 1.99%
(Updated on Dec 08, 2021)

Sell candidate since 2021-12-08

The Eagle Pharmaceuticals stock price fell by -1.99% on the last day (Wednesday, 8th Dec 2021) from $47.62 to $46.67. During the day the stock fluctuated 6.96% from a day low at $46.36 to a day high of $49.59. The price has fallen in 7 of the last 10 days and is down by -8.17% for this period. Volume has increased on the last day by 10 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 93 thousand shares were bought and sold for approximately $4.34 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.71% during the next 3 months and, with a 90% probability hold a price between $39.72 and $47.56 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, December 06, 2021, and so far it has risen 0.0858%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Eagle Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $47.50 and $50.56. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

Eagle Pharmaceuticals finds support from accumulated volume at $46.63 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.23 between high and low, or 6.96%. For the last week, the stock has had a daily average volatility of 4.29%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Eagle Pharmaceuticals stock A Buy?

Eagle Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.121

Predicted Opening Price for Eagle Pharmaceuticals of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$47.54 $46.67 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Sep 01, 2021 "Piper Sandler" gave "$48.00 - $51.00" rating for EGRX. The price target was changed from $53.24 to 0.2%.

Volatility and Risk
Daily Average Volatility: 4.29 %
Overall Risk: Very High High Medium Low Very Low
4.29 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $49.28
Price: $46.67
Support: $46.63

EGRX Insider Trading Show all Trades



Last 100 transactions
Buy: 1 129 841 | Sell: 451 004 (Shares)
Date Action Amount Person Type
Apr 28, 2021 Buy 13 500 Borio Luciana Stock Option (right to buy)
Apr 08, 2021 Buy 2 340 Ratoff Steven B Common Stock
Apr 08, 2021 Buy 2 340 Ratoff Steven B Common Stock
Apr 08, 2021 Sell 2 340 Ratoff Steven B Stock Option (right to buy)
Apr 08, 2021 Buy 2 340 Ratoff Steven B Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 1 129 841 | Sell: 451 004 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 50.76 8.77 %
49.53 6.13 %
48.77 4.50 %
Current price: 46.67
Support 46.31 -0.78 %
45.55 -2.41 %
44.31 -5.05 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 56.18 20.38 %
51.95 11.31 %
49.28 5.59 %
Current price 46.67
Support 46.63 -0.0857%
0 .
0 .

Click to get the best stock tips daily for free!

About Eagle Pharmaceuticals

Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban to treat heparin-induced thrombocytopenia; Ryanodex injectable suspension for the treatment of malignant hyperthermia; non-alcohol docetaxel injection, a chemotherapeutic agent for the treatment of breast, non-small cell ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE